Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,098.1
₹60,955 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹27,452.3
₹58,334 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,379.7
₹29,964 Cr
Pharmaceuticals & Drugs
₹890.1
₹17,496 Cr
Pharmaceuticals & Drugs
₹606.4
₹5,495 Cr
Pharmaceuticals & Drugs
₹520.8
₹4,788 Cr
Pharmaceuticals & Drugs
₹394.7
₹4,414 Cr
Pharmaceuticals & Drugs
₹102.8
₹2,640 Cr
Pharmaceuticals & Drugs
₹1,290.3
₹736 Cr
Pharmaceuticals & Drugs
₹47.7
₹134 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,098.1
₹12,668 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹890.1
₹6,229 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,379.7
₹4,209 Cr
Pharmaceuticals & Drugs
₹520.8
₹2,529 Cr
Pharmaceuticals & Drugs
₹606.4
₹1,853 Cr
Pharmaceuticals & Drugs
₹394.7
₹624 Cr
Pharmaceuticals & Drugs
₹102.8
₹157 Cr
Pharmaceuticals & Drugs
₹27,452.3
₹5,849 Cr
Pharmaceuticals & Drugs
₹1,290.3
₹362 Cr
Pharmaceuticals & Drugs
₹47.7
₹396 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹5,098.1
₹1,811 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,379.7
₹816 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹890.1
₹617 Cr
Pharmaceuticals & Drugs
₹606.4
₹217 Cr
Pharmaceuticals & Drugs
₹520.8
₹172 Cr
Pharmaceuticals & Drugs
₹394.7
₹137 Cr
Pharmaceuticals & Drugs
₹102.8
₹93 Cr
Pharmaceuticals & Drugs
₹27,452.3
₹1,201 Cr
Pharmaceuticals & Drugs
₹1,290.3
₹75 Cr
Pharmaceuticals & Drugs
₹47.7
₹6 Cr

You may also like the below Video Courses